The pharmaceutical industry stands at a pivotal juncture – one defined by digital transformation reshaping operations, the ethical and business imperative that is sustainability, and truly collaborative partnerships that are unlocking innovation at an unprecedented scale. The CPHI Pharma Awards 2026 aim to celebrate the breakthroughs and purposeful work defining the industry’s future.
The evolution of the pharmaceutical industry has similarly shaped our 2026 programme and the future of CPHI events. We have refined and expanded our award categories to capture these emerging trends: integrated delivery solutions, ecosystem-enabling innovation, environmental leadership, and partnership excellence that creates systemic change.
Dynamic categories for a changing industry
Leading this evolution of the CPHI Pharma Award categories, digital transformation celebrates organisations achieving measurable operational gains through strategic technology adoption, modernising workflows, and delivering competitive advantage. Building on this foundation, the Innovation Catalyst award represents our most forward-thinking addition; in recognising foundational innovations that enable others to build and connect, we hope to celebrate the power of collaboration in driving innovation. These platforms, standards, and frameworks create multiplier effects across the pharmaceutical ecosystem, amplifying the digital revolution’s impact on the wider pharmaceutical industry.
Sustainability and partnerships redefined
Recognising sustainability’s growing complexity, we have rethought and reshaped this area, splitting it into two refined categories. The Sustainable Pharma Excellence award spotlights transformative environmental innovations, from breakthrough green chemistry to clean manufacturing technologies and circular economy initiatives. Complementing individual excellence, the Sustainable Transformation Partnership award celebrates cross-sector partnerships delivering systemic change through sustainable supplier networks and strategic alliances that create lasting impact beyond individual organisations.
This collaborative spirit extends throughout our partnership categories. Our True Partnership Excellence award focuses on CDMOs/CMOs that transcend traditional service provision to become genuine innovation partners through collaboration and strategic value creation. Meanwhile, Excellence with Purpose celebrates initiatives proving that putting patients and communities first drives both meaningful social impact and sustainable business success – the ultimate partnership between industry and society.
The premier platform for pharmaceutical excellence
The CPHI Pharma Awards stand as the industry’s most prestigious recognition programme, offering unparalleled reach across the global pharmaceutical ecosystem. This isn’t just recognition; it is connection to the right partnerships, opportunities, and conversations that drive the industry forward.
Whether you have pioneered digital solutions, enabled ecosystem-wide innovation, delivered environmental breakthroughs, forged transformative partnerships, or championed patient-first initiatives, the CPHI Pharma Awards provide the perfect stage to showcase your impact. Your story could inspire the next wave of pharmaceutical innovation and connect you with partners who share your vision for the industry’s future.
Don’t miss this opportunity to gain global recognition and join the conversation shaping pharma’s tomorrow. Submit your entry today — deadline is May 16, 2026. At the heart of Pharma.
